Valuation Ocugen, Inc.

Stocks

Real-time Estimate Cboe BZX 11:17:57 2026-10-23 EDT			5-day change	1st Jan Change
0.7470 ^USD	-5.44%		-4.63%	-44.87%

10-14	Ocugen, Inc. Enters Into License Agreement With Roots Pharmaceutical And Al-Dhow International Holding For OCU400 Modifier Gene Therapy For Retinitis Pigmentosa In The Middle East And North Africa	CI
10-14	Ocugen Signs MENA Licensing Deal for OCU400	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	906.3	284.6	147.5	234.5	421.6	267.9	-	-
Change	-	-68.6%	-48.17%	59%	79.79%	-36.46%	-	-
Enterprise Value (EV) ¹	906.3	284.6	147.5	234.5	421.6	201.3	267.9	267.9
Change	-	-68.6%	-48.17%	59%	79.79%	-52.26%	33.09%	0%
P/E	-15.2x	-3.42x	-2.21x	-4.03x	-5.87x	-3.06x	-2.93x	-28.7x
PBR	-	-	-	-	-	-	-	-
PEG	-	-0.1x	0.1x	0.2x	-0.4x	-0.2x	-0.65x	0.3x
Capitalization / Revenue	-	-	24.4x	57.8x	95.5x	54x	48.7x	1.82x
EV / Revenue	-	-	24.4x	57.8x	95.5x	40.6x	48.7x	1.82x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-15.6x	-3.35x	-2.25x	-4.28x	-6.7x	-2.8x	-3.16x	-631x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.3	-0.38	-0.26	-0.2	-0.23	-0.2583	-0.27	-0.0275
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	6.036	4.055	4.413	4.957	5.5	147.1
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-58.03	-84.87	-65.53	-54.76	-62.92	-71.96	-84.7	-0.4245
Net income ¹	-58.36	-81.35	-63.08	-54.05	-67.85	-86.69	-94.65	-10.4
Net Debt ¹	-	-	-	-	-	-66.6	-	-
Reference price ²	4.5500	1.3000	0.5750	0.8050	1.3500	0.7900	0.7900	0.7900
Nbr of stocks (in thousands)	199,186	218,887	256,502	291,320	312,320	339,110	-	-
Announcement Date	2/25/22	2/28/23	4/16/24	3/5/25	3/4/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
OCUGEN, INC.	-3.06x	40.61x	-	-	268M
WUXI APPTEC CO., LTD.	18.38x	6.48x	12.88x	1.62%	63.29B
ARGENX SE	30.22x	7.94x	26.49x	0.05%	54.89B
LONZA GROUP AG	36.58x	6.5x	19.41x	0.88%	53.28B
IQVIA HOLDINGS INC.	35.46x	3.44x	14.83x	-.--%	45.81B
BEONE MEDICINES AG	50.32x	5.82x	31.95x	-.--%	43.46B
REVOLUTION MEDICINES, INC.	-19.48x	188.5x	-20.74x	-.--%	40.23B
CELLTRION, INC.	29.02x	8.23x	21.28x	0.37%	33.45B
WUXI BIOLOGICS (CAYMAN) INC.	27.38x	5.77x	14.95x	-.--%	23.7B
GENMAB A/S	32.79x	5.99x	20.16x	-.--%	23.76B
Average	23.76x	27.93x	15.69x	0.32%	38.21B
Weighted average by Cap.	26.68x	25.52x	15.93x	0.43%